Skip to main content
SkinCited

Vitamin D için Eczema (Atopic Dermatitis)

B Kanıt Bunu büyük ölçüde tutarlı sonuçlarla en az bir randomize çalışma desteklemektedir.

A meta-analysis found vitamin D supplementation was associated with significantly improved SCORAD scores in atopic dermatitis patients, particularly those with documented vitamin D deficiency.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'skincited.com'; const params = 'ingredient\u003Dvitamin\u002Dd\u0026condition\u003Deczema\u002Datopic\u002Ddermatitis'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

Sonuç

A meta-analysis found vitamin D supplementation was associated with significantly improved SCORAD scores in atopic dermatitis patients, particularly those with documented vitamin D deficiency.

Key Study Findings

Observational Study n=573
Vitiligo: Clinical and Laboratory Characteristics in 573 Saudi Patients.
Dose: None vs: None Outcome: Vitiligo prevalence and clinical characteristics Etki: None None

Popülasyon: Saudi patients with vitiligo (573)

retrospective observational with Mendelian randomization
Association of vitamin D with risk of warts: A retrospective and Mendelian randomization study.
Dose: None vs: Placebo Etki: OR 1.86 (95% CI 1.19-2.92) 0.007
Review
Nutritional Supplements for Skin Health-A Review of What Should Be Chosen and Why.
Dose: 14 nutritional compounds (vitamins, minerals, etc.) vs: None Outcome: Skin health and barrier function Etki: None None

Popülasyon: General population (skin health review)

Review
The Role of VD/VDR Signaling Pathway in Autoimmune Skin Diseases.
Dose: None vs: None Outcome: hair regrowth Etki: None None

Popülasyon: None

Case Reports
Vitamin B12 and Atopic Dermatitis: Any Therapeutic Relevance For Oral Supplementation?
Dose: None vs: None Outcome: Atopic dermatitis symptoms Etki: None None

Popülasyon: Patients with atopic dermatitis

Other
Nutrition and Atopic Dermatitis.
Dose: None vs: None Outcome: None Etki: None None

Popülasyon: None

Key Statistics

12

Çalışmalar

1800

Katılımcılar

Positive

B

Derece

Referenced Papers

Journal of Nippon … 2021 26 atıf
Alternative therapies in … 2021 10 atıf
Journal of the … 2020 57 atıf
Actas dermo-sifiliograficas 2019 43 atıf
American journal of … 2018 138 atıf
Clinics in dermatology 2016 19 atıf
The Cochrane database … 2012 130 atıf
Acta scientiarum polonorum. … 2012 11 atıf

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Yaygın Kullanılan Dozajlar

general:
600-800 IU/day (RDA)
skinhealth:
1,000-4,000 IU/day (targeting 30-50 ng/mL serum 25(OH)D)

Üst sınır: 4,000 IU/day (IOM); many experts consider up to 10,000 IU/day safe

Araştırmalarda İncelenen Dozajlar

Dozaj Süre Etki N
None -- Neutral 573
None -- Mixed --
14 nutritional compounds (vitamins, minerals, etc.) -- Positive --
None -- Mixed --
None -- Positive --
None -- Positive --
None -- Positive --
92.1% 36 weeks Positive 38

En iyi alım zamanı: With meals containing fat for better absorption

Safety & Side Effects

Bildirilen Yan Etkiler

  • Generally well-tolerated at recommended doses
  • Hypercalcemia at very high doses (nausea, vomiting, weakness)
  • Kidney stones (rare, at excessive doses)

Bilinen Etkileşimler

  • Thiazide diuretics (may increase calcium levels)
  • Corticosteroids (may reduce vitamin D absorption)
  • Orlistat and cholestyramine (reduce absorption of fat-soluble vitamins)
  • Calcipotriene (additive vitamin D effect)

Tolere edilebilir üst alım: 4,000 IU/day (IOM); many experts consider up to 10,000 IU/day safe

Herhangi bir takviye kullanmaya başlamadan önce mutlaka sağlık uzmanınıza danışın.Herhangi bir takviye başlatmadan önce her zaman sağlık uzmanınıza danışın.

Frequently Asked Questions

Does Vitamin D help with Eczema (Atopic Dermatitis)?
Based on 12 studies with 1,800 participants, there is moderate evidence from clinical studies that Vitamin D may support Eczema (Atopic Dermatitis) management. Our evidence grade is B (Good Evidence).
How much Vitamin D should I take for Eczema (Atopic Dermatitis)?
Studies have used various dosages. A commonly studied range is 600-800 IU/day (RDA). Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Vitamin D?
Reported side effects may include Generally well-tolerated at recommended doses, Hypercalcemia at very high doses (nausea, vomiting, weakness), Kidney stones (rare, at excessive doses). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Vitamin D and Eczema (Atopic Dermatitis)?
We rate the evidence as Grade B (Good Evidence). This rating is based on 12 peer-reviewed studies with 1,800 total participants. The overall direction of effect is positive.

Şu durum için diğer içerikler: Eczema (Atopic Dermatitis)

Vitamin D diğer sağlık durumları için

References

  1. [1] Mohammed Ibrahim AlJasser. Clin Cosmet Investig Dermatol. 2024. Vitiligo: Clinical and Laboratory Characteristics in 573 Saudi Patients. doi:10.2147/CCID.S499794 PubMed
  2. [2] Yuting Cao et al.. Skin Res Technol. 2024. Association of vitamin D with risk of warts: A retrospective and Mendelian randomization study. doi:10.1111/srt.13911 PubMed
  3. [3] Jacek Januszewski et al.. Medicina (Kaunas). 2023. Nutritional Supplements for Skin Health-A Review of What Should Be Chosen and Why. doi:10.3390/medicina60010068 PubMed
  4. [4] Yilan Zeng et al.. Mini Rev Med Chem. 2023. The Role of VD/VDR Signaling Pathway in Autoimmune Skin Diseases. doi:10.2174/1389557523666221124123206 PubMed
  5. [5] Davide Chesini Ms et al.. J Diet Suppl. 2022. Vitamin B12 and Atopic Dermatitis: Any Therapeutic Relevance For Oral Supplementation? doi:10.1080/19390211.2020.1860180 PubMed
  6. [6] Naoko Kanda et al.. J Nippon Med Sch. 2021. Nutrition and Atopic Dermatitis. doi:10.1272/jnms.JNMS.2021_88-317 PubMed
  7. [7] Basak Yalici-Armagan et al.. Int J Clin Pract. 2021. Paediatric lichen sclerosus et atrophicus: A retrospective analysis of 38 paediatric patients. doi:10.1111/ijcp.14661 PubMed
  8. [8] Kathleen M Coerdt et al.. Altern Ther Health Med. 2021. Vitamins A, B, C, and D: A Short Review for the Dermatologist. PubMed
  9. [9] R Z Conic et al.. J Eur Acad Dermatol Venereol. 2020. Comorbidities in pediatric alopecia areata. doi:10.1111/jdv.16727 PubMed
  10. [10] Amare Abera Tareke et al.. World Allergy Organ J. 2020. Prenatal vitamin D supplementation and child respiratory health: A systematic review and meta-analysis of randomized controlled trials. doi:10.1016/j.waojou.2020.100486 PubMed
  11. [11] F J Navarro-Triviño et al.. Actas Dermosifiliogr (Engl Ed). 2019. Vitamin D and the Skin: A Review for Dermatologists. doi:10.1016/j.ad.2018.08.006 PubMed
  12. [12] Elio Kechichian et al.. Am J Clin Dermatol. 2018. Vitamin D and the Skin: An Update for Dermatologists. doi:10.1007/s40257-017-0323-8 PubMed
  13. [13] Ozlem Atan Sahin et al.. Int J Pediatr Otorhinolaryngol. 2016. The association of residential mold exposure and adenotonsillar hypertrophy in children living in damp environments. doi:10.1016/j.ijporl.2016.07.018 PubMed
  14. [14] Meagen McCusker et al.. Clin Dermatol. 2016. Nutrition and skin: Kids are not just little people. doi:10.1016/j.clindermatol.2016.07.004 PubMed
  15. [15] Fiona J Bath-Hextall et al.. Cochrane Database Syst Rev. 2012. Dietary supplements for established atopic eczema. doi:10.1002/14651858.CD005205.pub3 PubMed
  16. [16] Carlos Lifschitz. Acta Sci Pol Technol Aliment. 2012. New actions for old nutrients. PubMed
  17. [17] W SCHUCHARD. Dtsch Med Wochenschr. 1955. [The treatment of alopecia areata and of dyshidrotic eczema with milk protein bound vitamin D 2]. doi:10.1055/s-0028-1116437 PubMed

FDA Sorumluluk Reddi: Bu ifadeler Gıda ve İlaç Dairesi (FDA) tarafından değerlendirilmemiştir. Bu web sitesindeki ürünler ve bilgiler herhangi bir hastalığı teşhis etmek, tedavi etmek, iyileştirmek veya önlemek amacıyla tasarlanmamıştır. Sunulan kanıt dereceleri, yayımlanmış hakemli araştırmalarımızın analizine dayanmaktadır ve tıbbi tavsiye niteliği taşımamaktadır. Herhangi bir takviye rejimine başlamadan önce her zaman sağlık uzmanınıza danışın.